Related Experiment Video
Updated: Jun 8, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
Discovery of Benzo[d]imidazole-6-sulfonamides as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with
Alessandra Cipriano1, Ciro Milite1, Alessandra Feoli1
1Department of Pharmacy, University of Salerno, via Giovanni Paolo II 132, 84084, Fisciano (SA), Italy.
Abstract:
The bromodomain and extra-terminal (BET) family of proteins includes BRD2, BRD3, BRD4, and the testis-specific protein, BRDT, each containing two N-terminal tandem bromodomain (BRD) modules. Potent and selective inhibitors targeting the two bromodomains are required to elucidate their biological role(s), with potential clinical applications. In this study, we designed and synthesized a series of benzimidazole-6-sulfonamides starting from the azobenzene compounds MS436 (7 a) and MS611 (7 b) that exhibited preference for the first (BD1) over the second (BD2) BRD of BET family members. The most-promising compound (9 a) showed good binding potency and improved metabolic stability and selectivity towards BD1 with respect to the parent compounds.
Related Concept Videos
Electrophilic Aromatic Substitution: Chlorination and Bromination of Benzene
Electrophilic Aromatic Substitution: Fluorination and Iodination of Benzene
Dose-Response Relationship: Selectivity and Specificity
Inhibitors of Bacterial DNA Synthesis
Antifungal Agents
Anthelminthic Agents

